Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial

Elias Jabbour, Guillaume Richard‐Carpentier, Yuya Sasaki, Marina Konopleva, Keyur P. Patel, Kathryn G. Roberts, Zhaohui Gu, Feng Wang, Xuelin Huang, Koji Sasaki, Nicholas J. Short, Nitin Jain, Farhad Ravandi, Naval Daver, Tapan M. Kadia, Yesid Alvarado, Courtney D. DiNardo, Ghayas C. Issa, Naveen Pemmaraju, Guillermo Garcia‐Manero, Srđan Verstovšek, Sa Wang, Joseph D. Khoury, Jeffrey L. Jorgensen, Richard E. Champlin, Issa F. Khouri, Partow Kebriaei, Heather Schroeder, Maria Khouri, Charles G. Mullighan, Koichi Takahashi, Susan O’Brien, Hagop M. Kantarjian